PROTECT-CH is a UK-wide clinical trial to identify treatments that can protect care home residents from developing COVID-19.
"This important NIHR-funded study will evaluate prophylactic treatments for COVID-19 in care homes. The more proven clinical tools we can use to protect this very vulnerable group the better, so I encourage care home operators and residents to take part in this study."
- Professor Chris Whitty, Chief Medical Officer for England and co-lead for the National Institute for Health Research
Residents in care homes have suffered greatly during the COVID-19 pandemic. Many potential treatments have been proposed that might prevent COVID-19 but none have been tested in care homes. PROTECT-CH is a platform trial that will test one or more treatments with the aim of reducing the risk of care home residents catching the virus that causes COVID-19 and of developing severe disease. We will make the results of the study rapidly available to ensure that treatments can be introduced without delay and COVID-19 guidelines quickly updated.
People living in residential and nursing homes across the UK can take part, but first their care home must be part of the study. If you are a care home manager and want to take part, please complete this survey.
Further information about the study is available in this summary.
Take part in the trial
If you are a Care Home Manager and would be interested in hearing more about the trial and potentially taking part, please complete the expression of interest survey. Further information about the study is available in this summary.
Collaborators
This trial is supported by a grant to the University of Nottingham from UK Research and Innovation/National Institute for Health Research (NIHR).
This trial is being carried out in collaboration with the Universities: Nottingham, Cambridge, Surrey, Edinburgh, Warwick, UCL, QUB, Cardiff
